Use of adenosine deaminase and adenosinedeaminase modifier in preparation of medicamentfor wound repair in patient with diabetes

Abstract

The present disclosure provides use of adenosine deaminase (ADA) and an ADA modifier in preparation of a medicament for wound repair in a patient with diabetes. It is found for the first time that the ADA (EC 3.5.4.4) and a polyethylene glycol-modified adenosine deaminase (PEG-ADA) have a significant improvement effect on wound repair of type-2 diabetic mice, and the ADA or the ADA modifier can be developed into a medicament for treating diabetic wounds.

Dependencies are inferred from the claim text.